artemisinin has been researched along with Stomach Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guan, J; Huang, P; Li, F; Liu, L; Liu, Z; Lu, L; Qi, X; Su, T; Wang, D; Wang, Y | 1 |
Wang, YL; Zhang, HT; Zhang, J; Zhang, QX | 1 |
Alem, M; Shahbazfar, AA; Varmaghani, S; Zare, P | 1 |
3 other study(ies) available for artemisinin and Stomach Neoplasms
Article | Year |
---|---|
Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Topics: Animals; Anticarcinogenic Agents; Artemisinins; Artesunate; Bacterial Adhesion; Cell Line, Tumor; Cytokines; Helicobacter Infections; Helicobacter pylori; Humans; Mice, Inbred C57BL; Microbial Sensitivity Tests; NF-kappa B; Reactive Oxygen Species; Stomach Neoplasms | 2019 |
Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53.
Topics: Apoptosis; Artemisinins; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2014 |
Effects of coadministration of artemisinin and iron on histopathologicalalterations in the AGS gastric adenocarcinoma cell line.
Topics: Adenocarcinoma; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Shape; Dose-Response Relationship, Drug; Humans; Iron; Stomach Neoplasms; Vacuoles | 2017 |